In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance.
暂无分享,去创建一个
Susanne Bredenberg | Hans Lennernäs | H. Lennernäs | S. Bredenberg | B. Lennernäs | C. Nyström | Christer Nyström | M. Duberg | Bo Lennernäs | Anders Pettersson | Margareta Duberg | Marie Westerberg | M. Westerberg | A. Pettersson | Susanne Bredenberg
[1] J. Remon,et al. Bioavailability of hydrochlorothiazide: conventional versus freeze-dried tablets , 1998 .
[2] M. Ashburn,et al. Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report. , 1989, Anesthesiology.
[3] R. Portenoy,et al. Management of cancer pain , 1999, The Lancet.
[4] K. Foley,et al. Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.
[5] S. S. Kornblum,et al. A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone. , 1973, Journal of pharmaceutical sciences.
[6] C. Nyström,et al. The use of ordered mixtures for improving the dissolution rate of low solubility compounds& * , 1986, The Journal of pharmacy and pharmacology.
[7] G. Alderborn,et al. Evaluation of a permeametry technique for surface area measurements of coarse particulate materials , 1990 .
[8] B. Jönsson,et al. Physicochemical aspects of drug release. IV. The effect of carrier particle properties on the dissolution rate from ordered mixtures , 1986 .
[9] G. Alderborn,et al. Studies on direct compression of tablets X. Measurement of tablet surface area by permeametry , 1985 .
[10] The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] G. Flynn,et al. Solubility Behavior of Narcotic Analgesics in Aqueous Media: Solubilities and Dissociation Constants of Morphine, Fentanyl, and Sufentanil , 1989, Pharmaceutical Research.
[12] N. Slater. Therapeutic Drugs , 1992 .
[13] J. Conroy,et al. Management of cancer pain. , 1996, Southern medical journal.
[14] Raymond C Rowe,et al. Handbook of Pharmaceutical Excipients , 1994 .
[15] C. Nyström,et al. Physicochemical aspects of drug release XVII. The effect of drug surface area coverage to carrier materials on drug dissolution from ordered mixtures , 1993 .
[16] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .
[17] S. Bredenberg,et al. In‐vitro evaluation of bioadhesion in particulate systems and possible improvement using interactive mixtures , 2003, The Journal of pharmacy and pharmacology.
[18] Ruggero Bettini,et al. Handbook of Pharmaceutical Excipients, Third Edition: Arthur H. Kibbe (ed.), Pharmaceutical Press, London, 2000, 665 pp. , 2001 .
[19] C. Nyström,et al. Dissolution rate measurements of sparingly soluble compounds with the Coulter Counter model TAII § , 1985, The Journal of pharmacy and pharmacology.
[20] R. Portenoy,et al. Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.
[21] G. Zeppetella. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study , 2001, Palliative medicine.
[22] Jie Zhang,et al. Oral Mucosal Drug Delivery , 2002, Clinical pharmacokinetics.
[23] R. Portenoy,et al. Management of cancer pain , 1999, The Lancet.
[24] R. Walton,et al. ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA , 1935 .
[25] D. McClain,et al. Intravenous fentanyl kinetics , 1980, Clinical pharmacology and therapeutics.
[26] Richard Carter,et al. Breakthrough , 1966 .
[27] E. Kharasch,et al. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[28] J. Newton,et al. The effect of water content on the porosity and liquid saturation of extruded cylinders , 1995 .
[29] T. Egan,et al. Dose Proportionality and Pharmacokinetics of Oral Transmucosal Fentanyl Citrate , 1998, Anesthesiology.
[30] C. Nyström,et al. Studies on direct compression of tablets II. The influence of the particle size of a dry binder on the mechanical strength of tablets , 1982 .
[31] S. Bredenberg,et al. Formulation of high tensile strength rapidly disintegrating tablets : Evaluation of the effect of some binder properties , 2001 .
[32] S J Farr,et al. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. , 1998, British journal of clinical pharmacology.
[33] C. Nyström,et al. Physicochemical aspects of drug release: X. Investigation of the applicability of the cube root law for characterization of the dissolution rate of fine particulate materials , 1990 .
[34] M. Ashburn,et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. , 1991, Anesthesiology.
[35] C. Nyström,et al. Evaluation of Critical Binder Properties Affecting the Compactibility of Binary Mixtures , 2001, Drug Development and Industrial Pharmacy.
[36] C. Nyström,et al. Physicochemical aspects of drug release. XII. The effect of some carrier particle properties and lubricant admixture on drug dissolution from tableted ordered mixtures , 1991 .
[37] Andrea Gazzaniga,et al. Influence of porosity and formula solubility on disintegrant efficency in tablets , 1995 .
[38] C. Nyström,et al. Physicochemical aspects of drug release. XV. Investigation of diffusional transport in dissolution of suspended, sparingly soluble drugs , 1992 .
[39] G. Hanks,et al. ABC of palliative care: Difficult pain problems , 1997 .